The mouse organ of Corti develops in two steps: progenitor specification and differentiation. 3
The Fibroblast Growth Factor (FGF) signaling pathway also plays vital roles in organ of Corti 6 development (reviewed in Ebeid and Huh, 2017) . Studies utilizing cochlear explants showed 7 that inhibition of FGF signaling prior to and during stages of HC and SC differentiation resulted 8 in decreased HC and SC number (T. Hayashi, Ray, & Bermingham-McDonogh, 2008 ). 9
Signaling through FGF receptor 1 (FGFR1), in particular, is essential during this process. 10
Conditional deletion of Fgfr1 (Fgfr1-CKO) in the developing cochlear epithelium resulted in 11 dramatically reduced HC and SC number (Huh, Warchol, & Ornitz, 2015; Ono et al., 2014; 12 Pirvola et al., 2002) . This has been attributed to decreased Sox2 expression in the prosensory 13 domain of Fgfr1-CKO mice, leading to a defect in prosensory specification (Ono et al., 2014) . 14 15 FGF20 has been hypothesized to be the FGFR1 ligand during organ of Corti development. Both 16
in vitro inhibition of FGF20 with an anti-FGF20 antibody (T. Hayashi et al., 2008) and in vivo 17 knockout of Fgf20 (Fgf20-KO; Huh et al., 2012) led to decreased HC and SC number, similar to 18 the Fgfr1-CKO phenotype. However, the Fgf20-KO phenotype is clearly not as severe as that of 19
Fgfr1-CKO. Fgfr1-CKO mice are missing almost all OHCs and some IHCs (Ono et al., 2014) , 20
while Fgf20-KO mice are only missing 2/3 of OHCs and have a full complement of IHCs (Huh et  21 al., 2012). This suggests that another FGF ligand may be redundant with and compensating for 22 the loss of FGF20, the identity of which is currently unknown. 23
Another difference between Fgfr1-CKO and Fgf20-KO mice is the proposed mechanism 24 accounting for the decrease in HCs and SCs. Interestingly, unlike in Fgfr1-CKO mice, Sox2 25 expression in the prosensory domain is not disrupted in Fgf20-KO mice (Huh et al., 2012; Ono 26 et al., 2014). Rather, FGF20 seems to be involved during HC and SC differentiation. These 27 differences between the Fgfr1-CKO and Fgf20-KO phenotypes and their relationship with Sox2 28
suggest that FGF20/FGFR1 signaling has a more complex and as yet unexplained role during 29 organ of Corti development. 30 31 Here, we hypothesize that FGFR1 signaling has functions in both steps of organ of Corti 32 development: an earlier role in prosensory specification that involves Sox2, and a later role in 33 the initiation of differentiation. We provide evidence that FGF20 regulates differentiation but not 34 specification. We further show that Sox2 and Fgf20 interact to modulate the temporal buffer 35 between prosensory specification and differentiation. As these two steps occur along a 36 developmental pathway, we hypothesize that prosensory specification must occur prior to 37 differentiation for sensory epithelia to develop. In Sox2 hypomorph mice, prosensory 38 specification is delayed, while in Fgf20-KO mice, differentiation occurs prematurely. When 39 combined, these two defects led to differentiation attempting to initiate prior to the completion of 40 specification, particularly at the basal end of the cochlear duct, which has a smaller temporal 41 buffer between these two events. These results define unique functions of and complex 42 interactions among FGF20, FGFR1, and Sox2 during organ of Corti development and highlight 43 the importance of the timing of specification and differentiation along different regions of the 44 cochlear duct. 45 46 47
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decreased in Fgfr1-CKO cochleae (Figure 2A ), in agreement with previous findings (Huh et al., 1 2012; Ono et al., 2014; Pirvola et al., 2002) . This indicates that FGFR1 has an additional role, 2 independent of FGF20, in regulating Sox2, which is required for prosensory specification 3 (Kiernan et al., 2005) . We hypothesize that another FGF ligand signaling via FGFR1 regulates 4
Sox2 expression during prosensory specification, while FGF20 signaling via FGFR1 regulates 5 differentiation ( Figure 2C ). 6 7 We also wanted to confirm that FGF20 signals to epithelial FGFR1 at around the initiation of 8 differentiation. To do so, we examined the expression of Etv4 (also known as Pea3) and Etv5 9
(also known as Erm), two well-established downstream effectors of FGF signaling (Ornitz & Itoh, 10 2015) , by in situ hybridization. The expression of these two genes have been shown to be 11 downregulated with FGF signaling inhibition in E14 cochlear explants (T. Hayashi et al., 2008) . 12 At E14.5, there were two domains of Etv4 and Etv5 expression in control cochleae: one in the 13 prosensory domain, and one in the outer sulcus ( that FGF20 signals through epithelial FGFR1. 20 21 Previous studies have also reported a decrease in proliferation in the Kölliker's organ (neural to 22 the prosensory domain, Figure . This finding is consistent with an additional FGF ligand signaling via FGFR1, likely at an 27 earlier stage. We do not know whether the proliferation defect in the Kölliker's organ contributes 28 to the reduction in HC and SC number in Fgfr1-CKO mice. 29 30
Genetic rescue of the Fgf20-KO phenotype suggests that FGF20 is required for 31 differentiation 32 33 We have previously shown that recombinant FGF9, which is biochemically similar to FGF20 34 (Ornitz & Itoh, 2015; Zhang et al., 2006) , is able to rescue the loss of HCs and SCs in Fgf20- KO 35 explant cochleae (Huh et al., 2012) . Interestingly, while treatment with FGF9 at E13.5 and E14. 5 36 was able to rescue the Fgf20-KO phenotype, treatment at E15.5 was not. This temporal rescue 37 specificity suggests that FGF20 signaling is required for the initiation of HC and SC 38 differentiation. 39 40
To confirm the hypothesis that FGF20 is involved in differentiation and not specification ( Figure  41 2C), we sought to more accurately determine the temporal requirement of FGF20 signaling. To 42 achieve this, we developed an in vivo genetic rescue model of the Fgf20-KO phenotype by 43 ectopically expressing FGF9. We combined Fgf20 Cre with the Fgf20 Fgf20-rescue (Fgf20 Cre/βgal ;ROSA rtTA/+ ;TRE-Fgf9-IRES-eGfp) mice along with littermate controls: 46
Fgf20-het (Fgf20 Cre/+ ;ROSA rtTA ), Fgf9-OA (Fgf20 Cre/+ ;ROSA rtTA/+ ;TRE-Fgf9-IRES-eGfp), and 47
Fgf20-null (Fgf20 Cre/βgal ;ROSA rtTA ). These mice express the reverse tetracycline transactivator 48 (rtTA) in the Fgf20 Cre lineage, which contains the prosensory domain and the Kölliker's organ at 49 E13.5 to E15.5 (Huh et al., 2015) . In mice expressing TRE-Fgf9-IRES-eGfp, rtTA drives the 50 6 expression of FGF9 upon doxycycline (Dox) induction. The Fgf20 β gal allele is another Fgf20-null 1 allele, in which exon 1 of Fgf20 is replaced by a sequence encoding β -galactosidase. We 2 combined Fgf20 Cre with Fgf20 β gal to generate homozygous mutant mice to maintain a constant 3 dosage of Fgf20 Cre in control and knockouts. 4 5 Initially, pregnant dams were fed a Dox diet from E13.5 to E15.5 and pups were harvested at P0 6 to examine HC and SC development. As expected, Dox treatment itself did not appear to affect 7 HC or SC development in Fgf20-het and Fgf20-null cochleae, both of which showed the 8 expected phenotypes ( Figures 3A and 3B ). Ectopic expression of FGF9 during these stages 9
also did not affect HC or SC development in Fgf9-OA cochleae, showing that excess 10 FGF20/FGF9 was not sufficient to produce ectopic HCs and SCs. Notably, ectopic expression 11 of FGF9 resulted in a full rescue of the number and patterning of HCs and SCs in Fgf20-rescue 12
pups. The organ of Corti in these rescue pups had one row of IHCs, three rows of OHCs, and 13 five rows of SCs throughout the entire length of the cochlear duct, without any gaps (Figures 3A  14 and 3B). This shows that FGF20/FGF9 signaling at E13.5-E15.5 is sufficient for HC and SC To more precisely determine the timing of rescue sufficiency, we fed pregnant dams Dox for a 21 period of 24 hours starting at E13.5, E14.5, or E15.5. With E13.5 Dox, patterning and OHC 22 number in the basal turn of the cochlea were completely rescued ( Figure 3A ). However, OHC 23 number in the middle and particularly the apical turns were only partially rescued, resulting in 24 regions with two rows of OHCs instead of three. For instance, in the apical turn, OHC number 25 was restored to 81% of Fgf20-het mice, which is statistically significantly increased compared to 26 Fgf20-null, but also statistically significantly decreased compared to Fgf20-het, indicating partial 27 rescue ( Figure 3C ). With E14.5 Dox, patterning and OHC number in the middle and apical turns 28
were completely rescued. However, OHC number in the basal turn was not completely rescued, 29 with regions of one or two rows of OHCs, instead of three. With E15.5 Dox, patterning and OHC 30 number was not rescued in the basal and middle turns, as gaps still formed between islands of 31
HCs ( Figure 3A ). However, OHC number in the apical turn was partially rescued, with two or 32 three rows of OHCs not separated by gaps towards the tip of the apex. In all of these 33 experiments, the rescue of SCs followed the same pattern as that of OHCs ( Figure 3B ). 34 35 These rescue results show that FGF20/FGF9 is sufficient for OHC and SC differentiation in the 36 basal turn of the cochlea at E13.5, in the middle and apical turns at E14.5-E15.5, and in the tip 37 of the apical turn at E15.5. Since the initiation of HC and SC differentiation occurs in the 38 base/mid-base of the cochlea at E13.5 and progresses apically over the next few days, these 39 results strongly imply that FGF20 functions during the initiation of differentiation, rather than 40 prosensory specification, consistent with our model ( Figure 2C ). 41 42 Decrease in Sox2 expression results in similar phenotypes as disruptions to FGFR1 43 signaling 44 45 Our results and previous findings suggest that FGFR1 regulates prosensory specification via 46
Sox2 (Ono et al., 2014) . Mice with an inner ear-specific Sox2 hypomorphic mutation (Sox2 Ysb/Ysb , 47 see below) have defects in prosensory specification, accounting for a small loss of HCs and 48
SCs, whereas mice with inner-ear specific Sox2 null mutations have a complete lack of 49 prosensory specification and a complete absence of sensory epithelium (Kiernan et al., 2005) . 50 7 To examine how much the reduction in Sox2 expression in Fgfr1-CKO cochlea contributes to 1 the phenotype at P0, we combined the Sox2 -(Sox2 constitutive null) and Sox2 Ysb alleles to 2 closely examine the effects of reduction in Sox2 expression on organ of Corti development, on a  3  similar genetic background as our Fgf20-KO and Fgfr1- We generated a Sox2 allelic series of mice with the following genotypes, in order of highest to 10 lowest levels of OHCs and one row of IHCs ( Figure 4A ). Interestingly, there were occasional ectopic IHCs 16 medial (neural) to the normal row of IHCs, especially in the middle and apical turns of the 17
Sox2 Ysb/+ cochlea ( Figure 4A , arrowheads). However, there was no significant increase in IHC 18 number (total or normalized to length) compared to wildtype cochleae ( Figure 4D ). The 19
Sox2 Ysb/Ysb cochlea appeared much more abnormal, with gaps in the sensory epithelium that 20
lacked HCs and SCs in the basal turn ( Figures 4A and 4B ), similar to what was observed 21
previously (Kiernan et al., 2005) . Moreover, at the base, in the sensory islands between the 22 gaps, there were often four rows of OHCs and six rows of SCs. In the middle and apical turns, 23 there were the normal three rows of OHCs and five rows of SCs. There were also numerous 24 ectopic IHCs throughout the middle and apical turns, sometimes forming an entire second row 25 of cells ( Figure 4A of IHCs in Sox2 Ysb/Ysb cochleae did not significantly differ from that of wildtype cochleae ( Figure  28 4D). In terms of OHCs, Sox2 Ysb/Ysb cochleae exhibited a 40% decrease in total number 29 compared to wildtype cochleae ( Figure 4E ). This decrease was not quite as severe when 30 normalized to cochlear length (21% decrease). Strikingly, Sox2 Ysb/cochleae lacked almost all 31
HCs and SCs, except in the apical turn ( Figures 4A and 4B ). The decrease in OHC number 32 (93%) in Sox2 Ysb/cochleae compared to wildtype was more severe than the decrease in IHC 33 number (75%). Notably, IHC number was significantly decreased in the basal and middle turns, 34 but not in the apical turn ( genotypes, the number of SCs followed the pattern of loss of OHCs (Figures 4F and Figure  37 supplement 1C). 38 39
Overall, these results showed that the basal end of the cochlea is more sensitive to the loss of 40
Sox2 expression than the apical end. Furthermore, while both IHCs and OHCs were affected, 41
OHCs were more sensitive to decrease in Sox2 expression than IHCs. Importantly, both of 42 these features were found in Fgfr1-CKO cochleae, where the decrease in IHCs was only found 43 in the basal and middle turns and there were almost no OHCs along the entire cochlear duct 44 ( Figures 1A, 1D , 1E and Figure supplement 1A-1C). Therefore, we conclude that decrease in 45
Sox2 expression, leading to defects in prosensory specification, could account for the Fgfr1- 46 CKO phenotype. Furthermore, the decrease in Sox2 expression could also account for the 47 difference in severity between the Fgfr1-CKO and Fgf20-KO phenotypes, since Fgf20- KO 48 cochleae, which had normal Sox2 expression, did not have a decrease in the number of IHCs, 49
unlike Fgfr1-CKO and Sox2 Ysb/cochleae. 50 51 1 2 We sought to determine why a decrease in Sox2 expression more severely affected the basal 3 end of the cochlear duct. Initially, we examined Sox2 expression at E14.5. As expected, Sox2 4 expression was almost completely absent in Sox2 Ysb/cochleae ( Figure 5 -Figure supplement  5 1A). This decrease was not more severe at the basal turn of the cochlear duct, relative to the 6 middle and apical turns, suggesting that the more severe basal phenotype in Sox2 Ysb/cochleae 7 cannot be explained by differential Sox2 expression. 8 9 As described in the introduction, waves of cell cycle exit (marking the completion of prosensory 10 specification) and initiation of differentiation travel in opposite directions along the cochlear duct 11 during development, resulting in the basal end of the cochlear duct differentiating immediately 12 after specification. The apical end, meanwhile, exhibits a delay in differentiation, resulting in a 13 longer temporal buffer between specification and differentiation. In this developmental pathway, 14 specification must be completed prior to the initiation of differentiation. We reasoned, therefore, 15 that disruptions to the timing of prosensory specification will preferentially interfere with basal 16 sensory epithelia development. 17 18 To test this hypothesis, we examined cell cycle exit in the prosensory domain via Ki67 19 expression as a marker of the status of specification. Ki67 is expressed by cycling cells, but not 20 cells in G 0 (Scholzen & Gerdes, 2000) . In the developing cochlea at around E12.5 to E15.5, 21
Decrease in levels of Sox2 expression delays prosensory specification
cells of the prosensory domain, sometimes referred to as the zone of non-proliferation, have 22 turned off or are beginning to turn off Ki67 (P. Chen & Segil, 1999). At E14.5 in Sox2 Ysb/+ 23 cochleae, the prosensory domain along most of the cochlear duct (serial sections 2-6) has 24 turned off Ki67 expression, except at the very base (serial section 1; Figure 5A indicates that the wave of cell cycle exit, which starts at the apex, has reached the very base of 27 the cochlear duct. However, in Sox2 Ysb/cochleae, only the prosensory domain at the apical turn 28 of the cochlear duct (serial section 6) has turned off Ki67, not the mid-basal or basal turns 29 (serial sections 1-3); the middle turns (serial sections 4 and 5), meanwhile, were just starting to 30 turn off Ki67 ( Figure 5A , brackets). This indicates that cell cycle exit has only reached the 31 middle turn, suggesting a delay in prosensory specification. In addition, the nuclei of prosensory 32 domain cells shift away from the luminal surface of the cochlear epithelium upon specification 33 (Kelley, 2007) . This basal shift of nuclei localization within the cell leaves a blank space 34 between DAPI-stained nuclei and the luminal surface of the cochlear duct, which can be 35 visualized in all six serial sections in Sox2 Ysb/+ cochleae at E14.5 ( Figure 5A , asterisks). 36 However, in Sox2 Ysb/cochleae, cells of the prosensory domain mostly did not exhibit this nuclei 37 shift at E14.5. 38 39 At E15.5, the prosensory domain along the entire length of the cochlear duct has turned off Ki67 40 expression in both Sox2 Ysb/+ and Sox2 Ysb/cochleae ( Figure 5A , brackets), indicating that 41 prosensory specification in Sox2 Ysb/cochleae has caught up by this stage. Prosensory nuclei 42 localization has also begun to catch up at E15.5 in Sox2 Ysb/cochleae ( Figure 5A , asterisks). 43
Overall, these results suggest that prosensory specification is delayed in Sox2 Ysb/cochleae, but 44 not permanently disrupted. 45 46 We hypothesize that prosensory specification must occur prior to differentiation to generate HCs 47
and SCs. Therefore, the period of time in between cell cycle exit and the initiation of 48 differentiation represents a temporal buffer ( Figure 5B , green shading) preventing differentiation 49 from occurring prior to specification. As differentiation begins in the basal/mid-basal cochlear 50 turns shortly after specification, the delay in specification in Sox2 Ysb/cochleae leads to 51 9 progenitors not having been specified in time for differentiation at the basal end of the cochlear 1 duct ( Figure 5B , crosshatch pattern). We propose that this explains why the basal end of the 2 cochlea is more sensitive to decreases in the level of Sox2 expression. 3 4
Sox2 is upstream of Fgf20 5 6 While the delay in prosensory specification can explain the preferential loss of sensory 7 epithelium from the basal end of Sox2 hypomorph cochleae, it does not readily explain the 8 preferential loss of OHCs, relative to IHCs. Since this preference for OHC loss is reminiscent of 9
the Fgf20/Fgfr1 deletion phenotypes, we investigated the possibility that Sox2 may be upstream 10 of FGF20-FGFR1 signaling. Interestingly, both Etv4 and Etv5 were dramatically downregulated 11
in the prosensory domain of Sox2 Ysb/cochleae compared to control ( Figure 6A ). This shows 12 that FGF20-FGFR1 signaling was disrupted in the Sox2 hypomorph cochleae. Examination of 13
Fgfr1 and Fgf20 expression by in situ hybridization revealed that while Fgfr1 expression did not 14 appear to be affected in Sox2 Ysb/cochleae at E14.5, Fgf20 expression was absent ( Figure 6B ). 15 This suggests that while Fgfr1 functions upstream of Sox2, Fgf20 is downstream of Sox2. This 16 model predicts that Fgf20 expression would be downregulated in Fgfr1-CKO cochleae, which 17
was confirmed by in situ hybridization ( Figure 6C ). 18 19 The above results indicate that the loss of Fgf20 could partially account for the Sox2 Ysb/-20 phenotype. To determine whether loss of Fgf20 also causes delayed prosensory specification, 21 we examined Ki67 expression in Fgf20-KO cochleae. At E14.5, there was no detectable delay in 22 cell cycle exit in Fgf20-KO cochleae, as loss of Ki67 expression reached the base (serial section 23 1) in both control and Fgf20-KO cochleae ( Figure 6D , brackets). See Figure 6 - Figure  24 supplement 1A for serial "mid-modiolar" sections through the cochlea. There was also no 25 detectable delay in basal nuclei shift in Fgf20-KO cochleae ( Figure 6D , asterisks). These results 26
were expected as the Fgf20-KO phenotype is not more severe at the basal end of the cochlear 27
duct. This is also consistent with Fgf20 being required during differentiation rather than 28 prosensory specification ( Figure 6E ). However, these results do not answer whether and how 29 the loss of Fgf20 contributes to the Sox2 hypomorph phenotype. 30 31 We also wanted to investigate whether decrease in Sox2 expression can account for the 32 absence of proliferation in the Kölliker's organ of Fgfr1-CKO cochleae. Interestingly, EdU-33 incorporation was decreased in the Kölliker's organ in Sox2 Ysb/cochleae at E14.5, especially in 34 the region adjacent to the prosensory domain ( Figure 6 -Figure supplement 1B, bracket). 35 However, EdU-incorporation was not completely absent from the Kölliker's organ, unlike in 36
Fgfr1-CKO cochleae. This suggests that loss of Sox2 in combination with other factors 37 contribute to the Kölliker's organ phenotype in Fgfr1-CKO cochleae. 38 39
Sox2 and Fgf20 interact during cochlea development 40 41 To explore whether and how the loss of Fgf20 contributes to the Sox2 hypomorph phenotype, 42 we combined the Fgf20and Sox2 Ysb alleles to remove Fgf20 in the less severe Sox2 43 hypomorphic background. We also hypothesized that reducing Sox2 expression in Fgf20 -/mice 44 would recapitulate (or phenocopy) the more severe Fgfr1-CKO phenotype, in which FGF20 45 signaling is lost in addition to a decrease Sox2 expression. We interbred F1 mice from the same 46 parents to generate nine different F2 genotypes encompassing all possible combinations of the 47 Fgf20and Sox2 Ysb alleles: Fgf20 +/+ ;Sox2 +/+ , Fgf20 +/+ ;Sox2 Ysb/+ , Fgf20 +/-;Sox2 +/+ , Fgf20 +/-48 ;Sox2 Ysb/+ , Fgf20 +/+ ;Sox2 Ysb/Ysb , Fgf20 +/-;Sox2 Ysb/Ysb , Fgf20 -/-;Sox2 +/+ , Fgf20 -/-;Sox2 Ysb/+ , and Fgf20 -49 /-;Sox2 Ysb/Ysb (Figures 7A and 7B and data not shown). At P0, an overview of HCs and SCs 50 showed that the Fgf20 +/-;Sox2 Ysb/phenotype mostly resembled that of Fgf20 +/+ ;Sox2 +/+ , 1 Fgf20 +/+ ;Sox2 Ysb/+ , and Fgf20 +/-;Sox2 +/+ cochleae, except for the prevalence of ectopic IHCs 2 ( Figure 7A , arrowheads). The Fgf20 +/-;Sox2 Ysb/Ysb phenotype mostly resembled that of 3 Fgf20 +/+ ;Sox2 Ysb/Ysb cochleae, but with more gaps in the basal cochlear turn and two rows of 4
IHCs throughout the length of the cochlear duct, except where there were gaps. The Fgf20 -/-5 ;Sox2 Ysb/+ phenotype mostly resembled that of Fgf20 -/-;Sox2 +/+ cochleae, but with smaller 6 sensory islands in between gaps. The Fgf20 -/-;Sox2 Ysb/Ysb phenotype appeared by far the most 7 severe, with almost a complete absence of IHCs, OHCs, and SCs from the basal turn, and tiny 8 sensory islands in the middle turn; however, the apical turn appeared similar to that of Fgf20 -/-9 ;Sox2 Ysb/+ and Fgf20 -/-;Sox2 +/+ cochleae ( Figures 7A and 7B ). 10 11
Quantification of the phenotypes are presented in Figures 7D-7G and Figure supplement 1B-1D. 12 We analyzed the quantified P0 phenotype via two-way ANOVA with the gene dosage of Fgf20 13
(levels: Fgf20 +/+ , Fgf20 +/-, Fgf20 -/-) and Sox2 (levels: OHCs, and SCs were all significantly affected by both the Fgf20 dosage and the Sox2 dosage, 17
as well as an interaction between the two factors ( Figures 7C-7G ). The statistically significant 18
interaction between Fgf20 and Sox2 dosages suggests that Fgf20 and Sox2 have a genetic 19
interaction. Notably, Fgf20 +/-;Sox2 Ysb/Ysb cochleae had significantly fewer OHCs and SCs than 20 Fgf20 +/+ ;Sox2 Ysb/Ysb cochleae, and Fgf20 -/-;Sox2 Ysb/+ cochleae had significantly fewer OHCs than 21
Fgf20 -/-;Sox2 +/+ cochleae. Importantly, Fgf20 -/-;Sox2 Ysb/Ysb cochleae had decreased total and 22 length-normalized number of IHCs, which was not observed in any of the other genotypes, 23 strongly supporting a genetic interaction between Fgf20 and Sox2 (Fgf20 +/+ ;Sox2 Ysb/Ysb cochleae 24 did have a slight decrease in the total number IHCs, but not in the length-normalized number of 25 IHCs). 26 27 Interestingly, while the total number of IHCs was decreased in Fgf20 -/-;Sox2 Ysb/Ysb cochleae 28
relative to all other genotypes, this decrease was only found in the basal and middle turns, but 29 not the apical turn ( This is reminiscent of the Fgfr1-CKO and Sox2 Ysb/phenotypes. 32 33 To ensure that the Fgf20and Sox2 Ysb interaction is not purely an artifact of the Sox2 Ysb allele, 34 we generated Fgf20 +/+ ;Sox2 +/+ (wildtype), Fgf20 +/-;Sox2 +/+ (Fgf20-het), Fgf20 +/+ ;Sox2 +/- (Sox2-35 het), and Fgf20 +/-;Sox2 +/-(double het) mice to look for an epistatic interaction between the Fgf20 - 36 and Sox2alleles ( These results  1 confirm a genetic epistatic interaction between Fgf20 and Sox2.
Fgf20-KO organ of Corti exhibits premature differentiation 4 5
We propose that the Fgf20 -/-;Sox2 Ysb/Ysb phenotype lies in between that of Fgfr1-CKO and 6
Sox2 Ysb/in terms of severity of reductions in cochlear length and in the number of HCs and SCs. 7
We further hypothesize that these three phenotypes form a continuum with the Fgf20-KO 8 phenotype ( Figure 8A ). Along this continuum, all four genotypes lack FGF20 signaling, but vary 9
in the level of Sox2 expression and phenotype severity in the basal end of the cochlear duct and 10 the outer compartment (outer rows of OHCs and SCs). From this, and from the Fgf20and 11
Sox2 Ysb series of alleles, we conclude that the basal end of the cochlear duct and the outer 12 compartment are more sensitive to the loss of Fgf20 and Sox2, relative to the apical end and 13 inner compartment, respectively. 14 15 To determine what is mediating the Sox2 and Fgf20 interaction, we asked whether the similarity 16
between the Fgf20 -/-;Sox2 Ysb/Ysb and Sox2 Ysb/phenotypes could be explained by a further 17 decrease in Sox2 levels in Fgf20 -/-;Sox2 Ysb/Ysb cochleae from Sox2 Ysb/Ysb levels. In other words, 18 we asked whether loss of Fgf20 further reduces Sox2 expression on a Sox2 hypomorphic 19
background. Examination of prosensory domain Sox2 expression at E14.5 revealed, as 20 expected, that Fgf20 -/-;Sox2 Ysb/+ cochleae did not have a decrease in Sox2 expression 21 compared to Fgf20 +/-;Sox2 Ysb/+ ( regulate Sox2 expression. 27 28 Next, we asked whether Sox2 and Fgf20 interact to delay prosensory specification. We showed 29 that Fgf20-KO cochleae do not have a delay in prosensory specification ( Figure 6D ). However, 30 this does not rule out the possibility that the loss of Fgf20 on a Sox2 hypomorphic background 31 may contribute to a delay. We examined Ki67 expression at E14.5 and found that in Fgf20 +/-32 ;Sox2 Ysb/+ cochleae, prosensory domain cell cycle exit has reached the end of the base (serial 33 section 1; Figure 8B the very base. As expected, Fgf20 +/-;Sox2 Ysb/Ysb cochleae exhibited a slight delay in prosensory 36 specification; cell cycle exit has reached the base (serial section 2), but has not yet reached the 37 end of the base (serial section 1). Importantly, Fgf20 -/-;Sox2 Ysb/Ysb cochleae did not show a 38
further delay relative to Fgf20 +/-;Sox2 Ysb/Ysb . There was also no detectable delay in basal nuclei 39 shift in Fgf20 -/-;Sox2 Ysb/+ or Fgf20 -/-;Sox2 Ysb/Ysb cochleae ( Figure 8B , asterisks). These results 40
suggest that the loss of Fgf20 does not contribute to delayed specification and that the severity 41 of the Fgf20 -/-;Sox2 Ysb/Ysb basal phenotype cannot be completely attributed to delayed 42 specification. 43 44 We showed that Fgf20 likely plays a role during the initiation of differentiation. Previous studies 45
showed that deletion of both transcription factors Hey1 and Hey2 results in premature 46 differentiation in the organ of Corti (Benito-Gonzalez & Doetzlhofer, 2014). Furthermore, it has 47 been suggested that FGF signaling, in particular FGF20, regulates Hey1 and Hey2 expression 48 during this process (Benito-Gonzalez & Doetzlhofer, 2014; Tateya et al., 2013) . To test whether 49
Fgf20 is upstream of Hey1 and Hey2, we looked at the expression of the two transcription 50 factors via in situ hybridization. In Fgf20-KO cochleae at E14.5, Hey1 expression is 51 downregulated while Hey2 is almost completely absent compared to control ( Figure 8C ). To test 1 whether this leads to premature differentiation in Fgf20-KO cochleae, we examined myosin VI 2 (Myo6) expression, a marker of differentiated HCs (Benito-Gonzalez & Doetzlhofer, 2014). In 3 control cochleae at E14.5, no Myo6-expressing cells were found in serial sections through the 4 cochleae in all five embryos examined (0/5); however, in Fgf20-KO cochleae, Myo6-expressing 5
HCs were found in several serial sections in the mid-basal and basal turns of the cochleae in 6
four out of five embryos examined (4/5; Figure 8D ). In one Fgf20-KO embryo, Myo6-expressing 7
HCs were found up to the mid-apical turn of the cochlea (not shown). These results show that 8
there is premature differentiation in Fgf20-KO cochleae. 9 10
Similar to a delay in prosensory specification, premature differentiation narrows the temporal 11 buffer between the completion of specification and initiation of differentiation. In the context of a 12
slight delay in specification due to decreased Sox2 levels, premature differentiation from the 13 loss of Fgf20 can lead to an attempt at differentiation before specification, particularly in the 14 basal end of the cochlea. We conclude that Sox2 and Fgf20 interact to regulate the boundaries 15 of the temporal buffer, ensuring that differentiation begins after the completion of specification 16
( Figure 9 ). 17 18 Lastly, we examined proliferation in the Fgf20and Sox2 Ysb E14.5 cochleae. Interestingly, there 19 was a noticeable decrease in the number of EdU-incorporating cells in Kölliker's organ in Fgf20 -20 /-;Sox2 Ysb/Ysb cochleae, compared to Fgf20 +/-;Sox2 Ysb/+ , Fgf20 -/-;Sox2 Ysb/+ , and Fgf20 +/-;Sox2 Ysb/Ysb 21 cochleae ( Figure 8-Figure supplement 1C ). This phenotype is similar to that of Sox2 Ysb/-22 cochleae and is less severe than that of Fgfr1-CKO cochleae. These findings suggest that 23
Fgf20 and Sox2 interact to regulate proliferation in the Kölliker's organ, although other factors 24 downstream of Fgfr1 also contribute. 25 26 DISCUSSION 27 28 Fgfr1 is involved in prosensory specification and differentiation, while Fgf20 is only 29 involved in differentiation 30 31 Fgf20 reported that Fgf20-null mice do not have defects in prosensory specification, and have a 37 normally formed prosensory domain (Huh et al., 2012) . We further showed that FGF20 signaling 38
is important during the initiation stage of differentiation, and that mice lacking Fgf20 have gaps 39 in the differentiated sensory epithelium filled with undifferentiated prosensory progenitors. 40
However, other studies have shown in vitro that FGF20 regulates prosensory specification via 41
Sox2 ( we show that ectopic FGF9 signaling is sufficient to rescue the Fgf20-null phenotype in a 44 spatiotemporal pattern that matched the timing of differentiation along the length of the cochlear 45 duct. We conclude, therefore, that FGF20 is involved in differentiation and not in prosensory 46 specification. 47 48 Notably, the Fgf20-null phenotype, in which two-thirds of OHCs fail to develop, is not as severe 49 as the Fgfr1-conditional null phenotype, which lacks almost all OHCs as well as half of IHCs. 50 13 Potential explanations for this include differences in mouse genetic background, and the 1 existence of another redundant FGF ligand(s). To rule out the former, we examined here Fgf20-2 null and Fgfr1-conditional null mice on a similar genetic background, and replicated the 3 difference in phenotype severity. We also replicated the decrease in Sox2 expression in the 4 prosensory domain previously reported in Fgfr1-conditional null mice (Ono et al., 2014) . We 5
further reaffirmed that Sox2 expression in the prosensory domain is not affected by the loss of 6
Fgf20. This suggests that another FGF ligand signaling through FGFR1 is required to maintain 7
Sox2 expression during prosensory specification. The identity of this ligand is currently unknown. 8 9
Foxg1 Cre has been used in several studies to target the otic epithelium, including to conditionally 10 delete . One concern with Foxg1 Cre 11 is that it is a null allele (Hébert & McConnell, 2000) . expression. Therefore, the increased severity of Foxg1 Cre/+ ;Fgfr1 flox/cochleae relative to Fgf20 -/-20 cochleae is likely not attributable Foxg1 haploinsufficiency. 21 22 We hypothesized that the severity of the Fgfr1-conditional null phenotype is due to the loss of 23 FGF20 signaling during differentiation and decreased Sox2 expression causing disrupted 24 prosensory specification. Consistent with this hypothesis, the combination of Fgf20 -/and 25
Sox2 Ysb/Ysb mutations phenocopied Fgfr1 conditional null cochleae. The similarities in phenotype 26
include approximately a 30% reduction in cochlear length and almost a complete loss of OHCs 27
and SCs and approximately a 50% loss of IHCs. Interestingly, the Fgf20 -/-;Sox2 Ysb/Ysb phenotype 28
is also similar to the Sox2 Ysb/phenotype. We conclude that the Fgfr1 conditional null, Fgf20 -/-29 ;Sox2 Ysb/Ysb , and Sox2 Ysb/phenotypes likely lie along the same continuum, as these three 30 genotypes all exhibited a lack of Fgf20 expression or signaling and varying levels of Sox2 31 expression ( Figure 7D ). Fgf20-null cochleae, in which Sox2 expression was not affected, lies at 32 the mild end of this continuum. Interestingly, this continuum shows that in the absence of Fgf20 33 expression or signaling, reductions in the level of Sox2 most severely affected sensory 34 epithelium development of the cochlear base and the outer compartment. Moving from the 35
Fgf20 -/-(mild) end of the spectrum towards the Sox2 Ysb/-(severe) end, increasing numbers of 36 HCs and SCs are lost, preferentially form the cochlear base and the outer compartment. 37 38
Sox2 and Fgf20 interact to modulate a temporal buffer between specification and 39 differentiation 40 41 We show here conclusive evidence that Fgf20 and Sox2 have a strong genetic interaction 42 during cochlea development. While we hypothesize that Sox2 and Fgf20 are involved in distinct 43 steps during organ of Corti development (prosensory specification and differentiation, 44 respectively), there is nevertheless potential for a strong interaction. We propose that the timing 45 of specification and differentiation define a temporal buffer preventing differentiation from 46 initiating prior to the completion of specification, and that Sox2 and Fgf20 interact to modulate 47 the borders of this buffer. In a developmental pathway, the upstream event (specification) must 48 occur prior to the downstream event (differentiation). Therefore, loss of Sox2 and Fgf20 leading 49
to delayed specification and premature differentiation, respectively, disrupts the temporal buffer. 50
This disruption particularly affects development towards the basal end of the cochlear duct, 1 where the buffer is the narrowest (Figure 9 ). We further show that the cochlear base is also 2 sensitive to slight perturbations in Sox2 and Fgf20, as the loss of a copy of each gene leads to 3 hair cell defects in the base. The sensitivity of the cochlear base to genetic perturbations of 4
Sox2 and Fgf20 may be functionally and evolutionarily significant, due to the tonotopic 5 organization of the organ of Corti. The basal end of the organ of Corti detects high frequency 6
sound, while the apical end detects low frequency sound (Basch et al., 2016). Therefore, 7
disruptions to the cochlear base selectively causes high-frequency hearing loss. This further 8
suggests that the decoupling of specification and differentiation, resulting in delayed 9
differentiation of the cochlear apex, may offer a selective advantage in preferentially protecting 10 low-frequency sound detection over high-frequency sound detection against genetic 11
perturbations. 12 13
Here, we use cell cycle exit in the prosensory domain (also known as the zone of non-14 proliferation) as a marker for the completion of specification (Chen & Segil, 1999 determined that the best markers for full specification of the prosensory domain are cell cycle 20 exit and nuclei shift away from the cochlear luminal surface. 21 22
Notably, while we show the potential for a Sox2 and Fgf20 interaction in modulating the 23 temporal buffer between specification and differentiation, Sox2 also has known roles during HC 24 and 2016; Puligilla & Kelley, 2016) . Therefore, the genetic interaction may occur during 26 differentiation as well. While interaction at this stage may explain the preferential loss of outer 27 compartment cells in Sox2 and Fgf20 mutants, it does not explain the selective loss of basal 28 cochlear HCs and SCs. Therefore, we conclude that the Sox2 and Fgf20 interaction regulates 29 the temporal buffer, with potential further interactions during differentiation. 30 31 Outer compartment of the cochlear sensory epithelium is more sensitive to the loss of 32 Fgfr1, Fgf20, and Sox2 than the inner compartment. 33 34 In all of the genotypes we observed in this study, the loss of outer compartment cells (i.e. OHCs) 35 was predominant. Only in the most severe cases in which almost all OHCs were missing, as 36 seen in Fgfr1-CKO, Fgf20 -/-;Sox2 Ysb/Ysb , and Sox2 Ysb/cochleae, were IHCs also lost. Similarly, 37 reduction in SC number always preferentially affected the outermost cells. This suggests that 38 the organ of Corti outer compartment is more sensitive to the loss of Fgfr1, Fgf20, and Sox2 39 than the inner compartment. The combination of Fgf20and Sox2 Ysb alleles elegantly 40 demonstrates this: as the number of Fgf20and Sox2 Ysb alleles increased, the number of OHCs 41 progressively decreased. In the double homozygous mutants, the number of IHCs decreased as 42
well. 43 44
Previous studies noted that the dosage of Fgfr1 affects the degree of organ of Corti outer 45 compartment loss. In Fgfr1 hypomorphs with 80% reduction in transcription, only the third row of 46
OHCs were missing, while 90% hypomorphs had a slightly more severe phenotype (Pirvola et 47 al., 2002) . Therefore, Fgfr1 loss preferentially affects the outermost HCs. Other studies 48
suggested that the timing of Fgfr1 deletion affects Sox2 expression decrease and the degree of 49 outer compartment loss. When an earlier-expressed Cre driver (Six1enh21-Cre) was used to 50 15 conditionally delete Fgfr1, almost all OHCs and some IHCs were lost, with a 66% reduction in 1
Sox2 expression at E14.5 (Ono et al., 2014) . When a later-expressed Cre driver (Emx2 Cre ) was 2 used, many more OHCs and IHCs remained, with only a 12% reduction in Sox2 expression. Our 3 results are consistent with both of these studies. We show that FGF20-independent FGFR1 4 signaling and Sox2 are required early, affecting both IHC and OHC development, while FGF20-5 FGFR1 signaling is important during later stages, affecting only OHC development. 6 7
Differentiation in the cochlea not only occurs in a basal-to-apical gradient, but also occurs in an 8
orthogonal inner-to-outer gradient. That is, IHCs differentiate first, followed by each sequential 9
row of OHCs (Ping Chen, Johnson, Zoghbi, & Segil, 2002). This wave of differentiation suggests 10 that perhaps outer compartment HCs and SCs require a longer temporal buffer between 11 specification and differentiation. The genetic interaction between Sox2 and Fgf20 in modulating 12 this temporal buffer, therefore, could also account for the loss of outer compartment HCs and 13
SCs. We hypothesize that the requirement for a longer temporal buffer may also be involved in interesting and important topic for future studies. 25 26
Hey1/Hey2 double knockout cochleae do not exhibit a loss of OHCs to the extent of Fgf20- KO 27 cochleae, suggesting that other genes downstream of Fgf20 are important in organ of Corti 28 development Addressing potential interactions  31 between Sox2, Fgf20, N-Myc, and L-Myc is another topic for future studies. 32 33 Previously, we hypothesized that Fgf20 is strictly required for the differentiation of an outer 34 compartment progenitor (Huh et al., 2012) . However, data we present here show that Fgf20, on 35 a sensitized, Sox2 hypomorphic background, is also required for inner compartment 36 differentiation. We conclude that inner and outer compartment progenitors likely are not distinct 37
populations. Rather, all prosensory progenitors giving rise to the organ of Corti exist on an 38
inner-to-outer continuum. FGF20 signaling, in combination with other factors including Sox2, are 39 required for the proper development of all of these cells, though with varying sensitivities. 40 41
MATERIALS AND METHODS 42 43
Mice 44 45
Mice were group housed with littermates, in breeding pairs, or in a breeding harem (2 females to 46 1 male), with food and water provided ad libitum. 47 48
For timed-pregnancy experiments, embryonic day 0.5 (E0.5) was assigned as noon of the day 1 the vaginal plug was found. For postnatal experiments, postnatal day 0 (P0) was determined as 2 the day of birth. 3 4
Mice were of mixed sexes and maintained on a mixed C57BL/6J x 129X1/SvJ genetic 5
background. All mice were backcrossed at least three generations onto this background. The 6
following mouse lines were used: 7
• Fgf20 Cre (Fgf20 -): knockin allele containing a sequence encoding a GFP-Cre fusion 8
protein replacing exon 1 of Fgf20, resulting in a null mutation (Huh et al., 2015) . 9
• Fgf20 β gal : knockin allele containing a sequence encoding β -galactosidase (βgal) 10
replacing exon 1 of Fgf20, resulting in a null mutation (Huh et al., 2012) . 11
• Foxg1 Cre : knockin allele containing a sequence encoding Cre fused in-frame downstream 12 of the first 13 codons, resulting in a null mutation (Hébert & McConnell, 2000) . 13
• Tek O.C.T. compound (4583, VWR International, Radnor, PA) and frozen on dry ice. Serial 4 horizontal sections through base of the head were cut at 12 µm with a cryostat, dried at room 5 temperature, and stored at -80°C until use. 6 7
RNA in situ hybridization 8 9 Probe preparation: mouse cDNA plasmids containing the following inserts were used to make 10 RNA in situ probes, and were cut and transcribed with the indicated restriction enzyme (New 11
England Biolabs, Ipswich, MA) and RNA polymerase (New England Biolabs, Ipswich, MA): 12
Fgfr1 transmembrane domain (325 bp, HincII, T7, gift of K Peters), Fgf20 (653 bp, NcoI, Sp6), 13
Sox2 ( (40 mM  19 NaHCO 3 , 60 mM Na 2 CO 3 ) at 60°C for up to 30 min, depending on probe size. 20 21 Frozen section in situ hybridization: frozen slides were warmed for 20 min at room temperature 22 and then 5 min at 50°C on a slide warmer. Sections were fixed in 4% PFA in PBS for 20 min at 23 room temperature, washed x2 in PBS and treated with pre-warmed 10 µg/ml Proteinase K 24
(03115828001, Sigma-Aldrich, St. Louis, MO) in PBS for 7 min at 37°C. Sections were then 25 fixed in 4% PFA in PBS for 15 min at room temperature, washed x2 in PBS, acetylated in 0.25% 26 acetic anhydrate in 0.1M Triethanolamine, pH 8.0, for 10 min, and washed again in PBS. 27 Sections were then placed in pre-warmed hybridization buffer (50% formamide, 5x SSC buffer, 28 5 mM EDTA, 50 µg/ml yeast tRNA) for 3 h at 60°C in humidified chamber for prehybridization. 29
Sections were then hybridized in 10 µg/ml probe/hybridization buffer overnight (12-16 h) at 60°C. 30 The next day, sections were washed in 1x SSC for 10 min at 60°C, followed by Whole mount: cochleae were incubated in PBS + 0.5% Tween-20 (PBSTw) for 1 h to 49 permeabilize. Cochleae were then blocked using PBSTw + 5% donkey serum for 1 h and then 50 incubated in PBSTw + 1% donkey serum with the primary antibody overnight at 4°C. Cochleae 1 were then washed x3 in PBS and incubated in PBS + 1% Tween-20 with the secondary 2 antibody. After wash in PBS x3, cochleae were mounted in 95% glycerol with the sensory 3 epithelium facing up. 4 5
Frozen slides were warmed for 30 min at room temperature and washed in PBS before 6 incubating in PBS + 0.5% Triton X-100 (PBST) for 1 h to permeabilize the tissue. Sections were 7 then blocked using in PBST + 5% donkey serum for 1 h and then incubated in PBST + 1% 8 donkey serum with the primary antibody overnight at 4°C in a humidified chamber. Sections 9
were then washed x3 in PBS and incubated in PBS + 1% Triton X-100 with the secondary 10 antibody. After wash in PBS x3, slides were mounted in VectaShield antifade mounting medium 11
with DAPI (H-1200, Vector Labs, Burlingame, CA). 12 13
The following compounds and antibodies were used: 14
• Alexa Fluor 488-conjugated Phallodin (1:50, A12379, Invitrogen, Carlsbad, CA) 15
• Rabbit anti-p75NTR (1:300, AB1554, EMD Millipore, Burlington, MA) 16
• Rabbit anti-Prox1 (1:1000, ABN278, EMD Millipore, Burlington, MA) 17
• Goat anti-Sox2 ( along the entire length of the cochlea. Total cell counts were also normalized to cochlear length 7 and presented as cell count per 100 µm of cochlea (e.g. IHCs/100 µm). For cell quantification at 8 the basal, middle, and apical turns of the cochlea, the cochlear duct was evenly divided into 9 thirds, and total IHCs, OHCs, and SCs were quantified for each third and normalized to length. 10
For the Fgf20-rescue experiments in Figure 3 , IHCs, OHCs, and SCs from at least 300 µm 11 regions of the basal (10%), middle (40%), and apical (70%) turns of the cochleae were counted 12 and normalized to 100 µm along the length of the cochlear duct. 13 14
In Sox2 Ysb/cochleae, p75NTR expression was mostly absent, resulting in sensory islands 15 without p75NTR-expressing inner pillar cells. In these cochleae, HCs not associated with inner 16 pillar cells were presumed to be IHCs during quantification. When a curved line was drawn 17
connecting the p75NTR islands along the organ of Corti, these presumed IHCs were always 18 medial (neural) to that line. 19 20
Statistical analysis and plotting 21 22 All figures were made in Canvas X (ACD systems). Data analysis was performed using the 23 Python programming language (python.org) in Jupyter Notebook (jupyter.org) with the following 24 libraries: Pandas (pandas.pydata.org), NumPy (numpy.org) and SciPy (scipy.org). Plotting was 25 done using the Matplotlib library (matplotlib.org). Statistics (t-test, one-way ANOVA, and two-26 way ANOVA) were performed using the SciPy module Stats; Tukey's HSD was performed using 27 the Statsmodels package (statsmodels.org). All comparisons of two means were performed 28 using two-tailed, unpaired Student's t-test. For comparisons of more than two means, one-way 29
ANOVA was used, except in Figures 7 and supplement 1 , where two-way ANOVA was used, 30 with the factors being Fgf20 (levels: Fgf20 +/+ , Fgf20 +/-, Fgf20 -/-) and Sox2 (levels: The authors declare no competing interests. 6 7 REFERENCES 8 9 Ahmed two stages: unspecified progenitors (tan shading) undergo specification and cell cycle 26 exit to become prosensory cells (green shading), which then differentiate into hair cells 27 and supporting cells (HCs & SCs; red shading). In wildtype cochleae, cell cycle exit 28
(indicating completion of specification) begins at the apex of the cochlea and proceeds 29 basally. Afterwards, differentiation initiates at the mid-base of the cochlea and proceeds 30 basally and apically. Temporal buffer (green shading), which is narrow at the basal end 31 of the cochlea but wide at the apical end, refers to the time between cell cycle exit and 32 initiation of differentiation. In Sox2 hypomorph cochleae, specification and cell cycle exit 33 are delayed, resulting in failure to complete specification before initiation of 34 differentiation towards the basal end of the cochlea (crosshatch pattern). 35 See also 9 . Sox2 and Fgf20 interact to modulate a temporal buffer between specification and 4 differentiation 5
Model of the roles of Sox2 and Fgf20 in organ of Corti development, which occurs in two stages: 6 unspecified progenitors (tan shading) undergo specification and cell cycle exit to become 7 prosensory cells (green shading), which then differentiate into hair cells and supporting cells 8 (HCs & SCs; red shading). In wildtype cochleae, cell cycle exit (indicating completion of 9 specification) begins at the apex of the cochlea and proceeds basally. Afterwards, differentiation 10 initiates at the mid-base of the cochlea and proceeds basally and apically. Temporal buffer 11 (green shading), which is narrow at the basal end of the cochlea but wide at the apical end, 12 refers to the time between cell cycle exit and initiation of differentiation. In Sox2/Fgf20 mutant 13 cochleae, decrease in levels of Sox2 expression in the developing cochlea leads to delayed 14 prosensory specification (arrow 1), while loss of Fgf20 leads to premature differentiation due to 15 decreased levels of Hey1 and Hey2 expression (arrow 2). Loss of both Sox2 and Fgf20 leads to 16
narrowing of the temporal buffer between specification and differentiation, preferentially * * * * * p = 0.1 p < 0.001 p < 0.001 p = 0.2 p = 0.009 p = 0.003 p = 0.5 p = 0.8 p = 0.8 p = 0.6 p = 0.8 p = 0.5 Interaction p < 0.001 p < 0.001 p = 0.03 p < 0.001 p < 0.001 p < 0.001 p = 0.002 p = 0.2 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p = 0.3
IHC/100µm
T otal SC basal middle apical IHC p < 0.001 p < 0.001 p = 0.2 p < 0.001 p = 0.2 p = 0.01 p < 0.001 p < 0.001 p < 0.001 OHC p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p = 0.002 p = 0.002 p < 0.001 SC p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p = 0.01 p = 0.01 p = 0.7 
